$456M pandemic flu contract awarded by Ottawa
Friday, March 25, 2011 - 11:03
in Health & Medicine
Canada's next pandemic flu vaccine contract includes a $425.9 million deal for 10 years for GlaxoSmithKline Inc.
Canada's next pandemic flu vaccine contract includes a $425.9 million deal for 10 years for GlaxoSmithKline Inc.